TY - JOUR AU - Pachman, L. M. AU - Khojah, A. M. PY - 2018 DA - 2018// TI - Advances in juvenile dermatomyositis: myositis specific antibodies aid in understanding disease heterogeneity JO - J Pediatr VL - 195 UR - https://doi.org/10.1016/j.jpeds.2017.12.053 DO - 10.1016/j.jpeds.2017.12.053 ID - Pachman2018 ER - TY - JOUR AU - Tansley, S. L. AU - Simou, S. AU - Shaddick, G. AU - Betteridge, Z. E. AU - Almeida, B. AU - Gunawardena, H. AU - Thomson, W. AU - Beresford, M. W. AU - Midgley, A. AU - Muntoni, F. PY - 2017 DA - 2017// TI - Autoantibodies in juvenile-onset myositis: their diagnostic value and associated clinical phenotype in a large UK cohort JO - J Autoimmun VL - 84 UR - https://doi.org/10.1016/j.jaut.2017.06.007 DO - 10.1016/j.jaut.2017.06.007 ID - Tansley2017 ER - TY - JOUR AU - Rider, L. G. AU - Nistala, K. PY - 2016 DA - 2016// TI - The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes JO - J Intern Med VL - 280 UR - https://doi.org/10.1111/joim.12444 DO - 10.1111/joim.12444 ID - Rider2016 ER - TY - JOUR AU - Habers, G. E. AU - Huber, A. M. AU - Mamyrova, G. AU - Targoff, I. N. AU - O'Hanlon, T. P. AU - Adams, S. AU - Pandey, J. P. AU - Boonacker, C. AU - Brussel, M. AU - Miller, F. W. PY - 2016 DA - 2016// TI - Brief report: association of myositis autoantibodies, clinical features, and environmental exposures at illness onset with disease course in juvenile myositis JO - Arthritis Rheumatol VL - 68 UR - https://doi.org/10.1002/art.39466 DO - 10.1002/art.39466 ID - Habers2016 ER - TY - JOUR AU - Miller, F. W. AU - Lamb, J. A. AU - Schmidt, J. AU - Nagaraju, K. PY - 2018 DA - 2018// TI - Risk factors and disease mechanisms in myositis JO - Nat Rev Rheumatol VL - 14 UR - https://doi.org/10.1038/nrrheum.2018.48 DO - 10.1038/nrrheum.2018.48 ID - Miller2018 ER - TY - JOUR AU - Bilgic, H. AU - Ytterberg, S. R. AU - Amin, S. AU - McNallan, K. T. AU - Wilson, J. C. AU - Koeuth, T. AU - Ellingson, S. AU - Newman, B. AU - Bauer, J. W. AU - Peterson, E. J. PY - 2009 DA - 2009// TI - Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis JO - Arthritis Rheum VL - 60 UR - https://doi.org/10.1002/art.24936 DO - 10.1002/art.24936 ID - Bilgic2009 ER - TY - JOUR AU - Greenberg, S. A. AU - Higgs, B. W. AU - Morehouse, C. AU - Walsh, R. J. AU - Kong, S. W. AU - Brohawn, P. AU - Zhu, W. AU - Amato, A. AU - Salajegheh, M. AU - White, B. PY - 2012 DA - 2012// TI - Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis JO - Genes Immun VL - 13 UR - https://doi.org/10.1038/gene.2011.61 DO - 10.1038/gene.2011.61 ID - Greenberg2012 ER - TY - STD TI - Moneta GM, Pires Marafon D, Marasco E, Rosina S, Verardo M, Fiorillo C, Minetti C, Bracci-Laudiero L, Ravelli A, De Benedetti F, et al. Muscle expression of type I and type II interferons is increased in juvenile dermatomyositis and related to clinical and histological features. Arthritis Rheumatol. 2019;71(6):1011–21. ID - ref8 ER - TY - JOUR AU - Wong, D. AU - Kea, B. AU - Pesich, R. AU - Higgs, B. W. AU - Zhu, W. AU - Brown, P. AU - Yao, Y. AU - Fiorentino, D. PY - 2012 DA - 2012// TI - Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0029161 DO - 10.1371/journal.pone.0029161 ID - Wong2012 ER - TY - JOUR AU - Huard, C. AU - Gulla, S. V. AU - Bennett, D. V. AU - Coyle, A. J. AU - Vleugels, R. A. AU - Greenberg, S. A. PY - 2017 DA - 2017// TI - Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon beta in dermatomyositis JO - Br J Dermatol VL - 176 UR - https://doi.org/10.1111/bjd.15006 DO - 10.1111/bjd.15006 ID - Huard2017 ER - TY - JOUR AU - Baechler, E. C. AU - Bauer, J. W. AU - Slattery, C. A. AU - Ortmann, W. A. AU - Espe, K. J. AU - Novitzke, J. AU - Ytterberg, S. R. AU - Gregersen, P. K. AU - Behrens, T. W. AU - Reed, A. M. PY - 2007 DA - 2007// TI - An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity JO - Mol Med VL - 13 UR - https://doi.org/10.2119/2006-00085.Baechler DO - 10.2119/2006-00085.Baechler ID - Baechler2007 ER - TY - JOUR AU - Greenberg, S. A. AU - Pinkus, J. L. AU - Pinkus, G. S. AU - Burleson, T. AU - Sanoudou, D. AU - Tawil, R. AU - Barohn, R. J. AU - Saperstein, D. S. AU - Briemberg, H. R. AU - Ericsson, M. PY - 2005 DA - 2005// TI - Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis JO - Ann Neurol VL - 57 UR - https://doi.org/10.1002/ana.20464 DO - 10.1002/ana.20464 ID - Greenberg2005 ER - TY - JOUR AU - Fall, N. AU - Bove, K. E. AU - Stringer, K. AU - Lovell, D. J. AU - Brunner, H. I. AU - Weiss, J. AU - Higgins, G. C. AU - Bowyer, S. L. AU - Graham, T. B. AU - Thornton, S. PY - 2005 DA - 2005// TI - Association between lack of angiogenic response in muscle tissue and high expression of angiostatic ELR-negative CXC chemokines in patients with juvenile dermatomyositis: possible link to vasculopathy JO - Arthritis Rheum VL - 52 UR - https://doi.org/10.1002/art.21303 DO - 10.1002/art.21303 ID - Fall2005 ER - TY - JOUR AU - Brehm, A. AU - Liu, Y. AU - Sheikh, A. AU - Marrero, B. AU - Omoyinmi, E. AU - Zhou, Q. AU - Montealegre, G. AU - Biancotto, A. AU - Reinhardt, A. AU - Almeida de Jesus, A. PY - 2015 DA - 2015// TI - Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production JO - J Clin Invest VL - 125 UR - https://doi.org/10.1172/JCI81260 DO - 10.1172/JCI81260 ID - Brehm2015 ER - TY - JOUR AU - Liu, Y. AU - Ramot, Y. AU - Torrelo, A. AU - Paller, A. S. AU - Si, N. AU - Babay, S. AU - Kim, P. W. AU - Sheikh, A. AU - Lee, C. C. AU - Chen, Y. PY - 2012 DA - 2012// TI - Mutations in proteasome subunit beta type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity JO - Arthritis Rheum VL - 64 UR - https://doi.org/10.1002/art.33368 DO - 10.1002/art.33368 ID - Liu2012 ER - TY - JOUR AU - Kim, H. AU - Sanchez, G. A. AU - Goldbach-Mansky, R. PY - 2016 DA - 2016// TI - Insights from Mendelian interferonopathies: comparison of CANDLE, SAVI with AGS, monogenic lupus JO - J Mol Med (Berl) VL - 94 UR - https://doi.org/10.1007/s00109-016-1465-5 DO - 10.1007/s00109-016-1465-5 ID - Kim2016 ER - TY - JOUR AU - Liu, Y. AU - Jesus, A. A. AU - Marrero, B. AU - Yang, D. AU - Ramsey, S. E. AU - Montealegre Sanchez, G. A. AU - Tenbrock, K. AU - Wittkowski, H. AU - Jones, O. Y. AU - Kuehn, H. S. PY - 2014 DA - 2014// TI - Activated STING in a vascular and pulmonary syndrome JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1312625 DO - 10.1056/NEJMoa1312625 ID - Liu2014 ER - TY - JOUR AU - Rodero, M. P. AU - Crow, Y. J. PY - 2016 DA - 2016// TI - Type I interferon-mediated monogenic autoinflammation: the type I interferonopathies, a conceptual overview JO - J Exp Med VL - 213 UR - https://doi.org/10.1084/jem.20161596 DO - 10.1084/jem.20161596 ID - Rodero2016 ER - TY - JOUR AU - Jesus, A. A. AU - Canna, S. W. AU - Liu, Y. AU - Goldbach-Mansky, R. PY - 2015 DA - 2015// TI - Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling JO - Annu Rev Immunol VL - 33 UR - https://doi.org/10.1146/annurev-immunol-032414-112227 DO - 10.1146/annurev-immunol-032414-112227 ID - Jesus2015 ER - TY - JOUR AU - Sanchez, G. A. M. AU - Reinhardt, A. AU - Ramsey, S. AU - Wittkowski, H. AU - Hashkes, P. J. AU - Berkun, Y. AU - Schalm, S. AU - Murias, S. AU - Dare, J. A. AU - Brown, D. PY - 2018 DA - 2018// TI - JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies JO - J Clin Invest VL - 128 UR - https://doi.org/10.1172/JCI98814 DO - 10.1172/JCI98814 ID - Sanchez2018 ER - TY - JOUR AU - Torrelo, A. PY - 2017 DA - 2017// TI - CANDLE syndrome as a paradigm of proteasome-related autoinflammation JO - Front Immunol VL - 8 UR - https://doi.org/10.3389/fimmu.2017.00927 DO - 10.3389/fimmu.2017.00927 ID - Torrelo2017 ER - TY - JOUR AU - Kim, H. AU - Jesus, A. A. AU - Brooks, S. R. AU - Liu, Y. AU - Huang, Y. AU - VanTries, R. AU - Montealegre Sanchez, G. A. AU - Rotman, Y. AU - Gadina, M. AU - Goldbach-Mansky, R. PY - 2018 DA - 2018// TI - Development of a validated interferon score using NanoString technology JO - J Interf Cytokine Res VL - 38 UR - https://doi.org/10.1089/jir.2017.0127 DO - 10.1089/jir.2017.0127 ID - Kim2018 ER - TY - JOUR AU - Bohan, A. AU - Peter, J. B. PY - 1975 DA - 1975// TI - Polymyositis and dermatomyositis (first of two parts) JO - N Engl J Med VL - 292 UR - https://doi.org/10.1056/NEJM197502132920706 DO - 10.1056/NEJM197502132920706 ID - Bohan1975 ER - TY - JOUR AU - Trieu, E. P. AU - Targoff, I. N. PY - 2015 DA - 2015// TI - Immunoprecipitation: Western blot for proteins of low abundance JO - Methods Mol Biol VL - 1312 UR - https://doi.org/10.1007/978-1-4939-2694-7_34 DO - 10.1007/978-1-4939-2694-7_34 ID - Trieu2015 ER - TY - JOUR AU - Benjamini, Y. AU - Krieger, A. M. AU - Yekutieli, D. PY - 2006 DA - 2006// TI - Adaptive linear step-up procedures that control the false discovery rate JO - Biometrika VL - 93 UR - https://doi.org/10.1093/biomet/93.3.491 DO - 10.1093/biomet/93.3.491 ID - Benjamini2006 ER - TY - STD TI - de Jesus AA, Hou Y, Brooks S, Malle L, Biancotto A, Huang Y, Calvo KR, Marrero B, Moir S, Oler AJ, et al. Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases. J Clin Invest. 2020. https://doi.org/10.1172/JCI129301. ID - ref26 ER - TY - JOUR AU - Rider, L. G. AU - Aggarwal, R. AU - Machado, P. M. AU - Hogrel, J. Y. AU - Reed, A. M. AU - Christopher-Stine, L. AU - Ruperto, N. PY - 2018 DA - 2018// TI - Update on outcome assessment in myositis JO - Nat Rev Rheumatol VL - 14 UR - https://doi.org/10.1038/nrrheum.2018.33 DO - 10.1038/nrrheum.2018.33 ID - Rider2018 ER - TY - JOUR AU - Rice, G. I. AU - Melki, I. AU - Fremond, M. L. AU - Briggs, T. A. AU - Rodero, M. P. AU - Kitabayashi, N. AU - Oojageer, A. AU - Bader-Meunier, B. AU - Belot, A. AU - Bodemer, C. PY - 2017 DA - 2017// TI - Assessment of type I interferon signaling in pediatric inflammatory disease JO - J Clin Immunol VL - 37 UR - https://doi.org/10.1007/s10875-016-0359-1 DO - 10.1007/s10875-016-0359-1 ID - Rice2017 ER - TY - JOUR AU - Li, Y. AU - Li, C. AU - Xue, P. AU - Zhong, B. AU - Mao, A. P. AU - Ran, Y. AU - Chen, H. AU - Wang, Y. Y. AU - Yang, F. AU - Shu, H. B. PY - 2009 DA - 2009// TI - ISG56 is a negative-feedback regulator of virus-triggered signaling and cellular antiviral response JO - Proc Natl Acad Sci U S A VL - 106 UR - https://doi.org/10.1073/pnas.0900818106 DO - 10.1073/pnas.0900818106 ID - Li2009 ER - TY - JOUR AU - Crowe, W. E. AU - Bove, K. E. AU - Levinson, J. E. AU - Hilton, P. K. PY - 1982 DA - 1982// TI - Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis JO - Arthritis Rheum VL - 25 UR - https://doi.org/10.1002/art.1780250203 DO - 10.1002/art.1780250203 ID - Crowe1982 ER - TY - JOUR AU - Gitiaux, C. AU - Antonio, M. AU - Aouizerate, J. AU - Gherardi, R. K. AU - Guilbert, T. AU - Barnerias, C. AU - Bodemer, C. AU - Brochard-Payet, K. AU - Quartier, P. AU - Musset, L. PY - 2016 DA - 2016// TI - Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis JO - Rheumatology VL - 55 ID - Gitiaux2016 ER - TY - JOUR AU - Gadina, M. AU - Johnson, C. AU - Schwartz, D. AU - Bonelli, M. AU - Hasni, S. AU - Kanno, Y. AU - Changelian, P. AU - Laurence, A. AU - O’Shea, J. J. PY - 2018 DA - 2018// TI - Translational and clinical advances in JAK-STAT biology: the present and future of jakinibs JO - J Leukoc Biol VL - 104 UR - https://doi.org/10.1002/JLB.5RI0218-084R DO - 10.1002/JLB.5RI0218-084R ID - Gadina2018 ER - TY - JOUR AU - Fremond, M. L. AU - Rodero, M. P. AU - Jeremiah, N. AU - Belot, A. AU - Jeziorski, E. AU - Duffy, D. AU - Bessis, D. AU - Cros, G. AU - Rice, G. I. AU - Charbit, B. PY - 2016 DA - 2016// TI - Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children JO - J Allergy Clin Immunol VL - 138 UR - https://doi.org/10.1016/j.jaci.2016.07.015 DO - 10.1016/j.jaci.2016.07.015 ID - Fremond2016 ER - TY - JOUR AU - Aeschlimann, F. A. AU - Fremond, M. L. AU - Duffy, D. AU - Rice, G. I. AU - Charuel, J. L. AU - Bondet, V. AU - Saire, E. AU - Neven, B. AU - Bodemer, C. AU - Balu, L. PY - 2018 DA - 2018// TI - A child with severe juvenile dermatomyositis treated with ruxolitinib JO - Brain VL - 141 UR - https://doi.org/10.1093/brain/awy255 DO - 10.1093/brain/awy255 ID - Aeschlimann2018 ER - TY - STD TI - Papadopoulou C, Hong Y, Omoyinmi E, Brogan PA, Eleftheriou D. Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis. Brain. 2019;142(3):e8. ID - ref35 ER - TY - STD TI - Kato M, Ikeda K, Kageyama T, Kasuya T, Kumagai T, Furuya H, Furuta S, Tamachi T, Suto A, Suzuki K, et al. Successful treatment for refractory interstitial lung disease and pneumomediastinum with multidisciplinary therapy including tofacitinib in a patient with anti-MDA5 antibody-positive dermatomyositis. J Clin Rheumatol. 2019. https://doi.org/10.1097/RHU.0000000000000984. ID - ref36 ER - TY - JOUR AU - Kurasawa, K. AU - Arai, S. AU - Namiki, Y. AU - Tanaka, A. AU - Takamura, Y. AU - Owada, T. AU - Arima, M. AU - Maezawa, R. PY - 2018 DA - 2018// TI - Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis JO - Rheumatology VL - 57 UR - https://doi.org/10.1093/rheumatology/key188 DO - 10.1093/rheumatology/key188 ID - Kurasawa2018 ER - TY - JOUR AU - Sabbagh, S. AU - Almeida de Jesus, A. AU - Hwang, S. AU - Kuehn, H. S. AU - Kim, H. AU - Jung, L. AU - Carrasco, R. AU - Rosenzweig, S. AU - Goldbach-Mansky, R. AU - Rider, L. G. PY - 2019 DA - 2019// TI - Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib JO - Brain VL - 142 UR - https://doi.org/10.1093/brain/awz293 DO - 10.1093/brain/awz293 ID - Sabbagh2019 ER - TY - JOUR AU - Reed, A. M. AU - Crowson, C. S. AU - Hein, M. AU - Padilla, C. L. AU - Olazagasti, J. M. AU - Aggarwal, R. AU - Ascherman, D. P. AU - Levesque, M. C. AU - Oddis, C. V. PY - 2015 DA - 2015// TI - Biologic predictors of clinical improvement in rituximab-treated refractory myositis JO - BMC Musculoskelet Disord VL - 16 UR - https://doi.org/10.1186/s12891-015-0710-3 DO - 10.1186/s12891-015-0710-3 ID - Reed2015 ER - TY - JOUR AU - Nagaraju, K. AU - Ghimbovschi, S. AU - Rayavarapu, S. AU - Phadke, A. AU - Rider, L. G. AU - Hoffman, E. P. AU - Miller, F. W. PY - 2016 DA - 2016// TI - Muscle myeloid type I interferon gene expression may predict therapeutic responses to rituximab in myositis patients JO - Rheumatology VL - 55 UR - https://doi.org/10.1093/rheumatology/kew213 DO - 10.1093/rheumatology/kew213 ID - Nagaraju2016 ER - TY - JOUR AU - Lopez De Padilla, C. M. AU - Crowson, C. S. AU - Hein, M. S. AU - Strausbauch, M. A. AU - Aggarwal, R. AU - Levesque, M. C. AU - Ascherman, D. P. AU - Oddis, C. V. AU - Reed, A. M. PY - 2015 DA - 2015// TI - Interferon-regulated chemokine score associated with improvement in disease activity in refractory myositis patients treated with rituximab JO - Clin Exp Rheumatol VL - 33 ID - Lopez De Padilla2015 ER -